True or False: Adolescents with overweight or obesity and asthma had a higher risk of exacerbations after starting a GLP-1 receptor agonist, according to a retrospective study. The CLARO trial showed ...
16hon MSN
Aspirin, CT scans and sleep: Five questions raised by Trump’s new disclosures on his health
It is not clear what test he was referring to in his post, and the White House did not immediately return a request for ...
Engaging System 2 requires significant metabolic energy. Your brain consumes a lot of your body’s energy as it is; intense ...
Despite limited uptake, weight-loss drugs have topped drug sales in India by value — marking a shift in how people perceive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback